Axa’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
Other funds holding ISEE
DTC
ACA
TCM
RG
Axa's ISEE Position: Q4 2022 in Review
Axa sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 28,400 shares — an estimated $509K sold.
Axa first reported a position in ISEE in Q3 2014 and held it in 14 quarters. The position peaked at $14.4M in Q4 2015. 225 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.
- Axa reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
- Axa sold 28,400 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $509K.
- Axa first reported a position in IVERIC bio, Inc. Common Stock in Q3 2014 and held it in 14 quarters.
- Axa's IVERIC bio, Inc. Common Stock position peaked at $14.4M in Q4 2015.
- 225 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.
Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.